在儿科重症监护中建立全球合作研究网络:路线图
Luregn J Schlapbach1, Padmanabhan Ramnarayan2, Kristen S Gibbons3
1Department of Intensive Care and Neonatology, and Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland; Children's Intensive Care Research Program, Child Health Research Centre, University of Queensland, Brisbane, QLD, Australia.
The Lancet. Child & adolescent health
|December 24, 2024
概括
制定路线图对于推进儿科重症监护研究至关重要. 该计划解决了诸如患者数量较低和资金用于改善全球重症儿童试验等挑战.
科学领域:
- 关键护理医学 关键护理医学
- 儿科健康 儿科健康
- 卫生政策研究 卫生政策研究
背景情况:
- 儿科重症监护病房为弱势儿童提供服务,但实践和政策的证据有限.
- 现有研究面临挑战,包括患者数量低,发育异质性和资金差异.
研究的目的:
- 为国际儿科重症监护试验提出战略路线图.
- 引导发展强大的研究基础设施和协作网络.
主要方法:
- 召集了一个由32名国际儿科重症监护专家组成的多学科小组.
- 确定了阻碍儿科重症监护研究的关键挑战.
- 提出了七点战略路线图,以改善试验设计和进行.
主要成果:
- 确定了主要挑战:患者数量低,异质性,同意问题,资金缺口和基础设施赤字.
- 提出了七点路线图,包括网络形成,工具包开发,数据协调和资助者倡导.
- 该路线图旨在促进针对不同儿科群体的试验设计和执行.
结论:
- 实施拟议的路线图对于推进儿科重症监护研究至关重要.
- 要克服现有的障碍,需要采用协作的国际方法.
- 该路线图为开展有影响力的试验提供了框架,以改善全球重症儿童的治疗结果.
更多相关视频
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...